RESPONSE OF THE BONE AND KIDNEY TO EHDP IN MAN

RESPONSE OF THE BONE AND KIDNEY TO EHDP IN MAN

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Russell, R, Douglas, D, Duckworth, T, Preston, C, Smith, T, Kanis, J, Walton, R, Woods, C, Smith, R
Μορφή:	Journal article
Έκδοση:	1979

Παρόμοια τεκμήρια

ABNORMAL RESPONSES TO EHDP TREATMENT OF PAGETS-DISEASE
ανά: Smith, R, κ.ά.
Έκδοση: (1977)

Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.
ανά: Walton, R, κ.ά.
Έκδοση: (1975)

Proceedings: Some effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium metabolism in man.
ανά: Walton, R, κ.ά.
Έκδοση: (1974)

STUDIES ON HYPERPHOSPHATEMIA INDUCED BY DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (EHDP) IN MAN
ανά: Walton, R, κ.ά.
Έκδοση: (1974)

Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.
ανά: Walton, R, κ.ά.
Έκδοση: (1976)

An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease.
ανά: Walton, R, κ.ά.
Έκδοση: (1975)

Histological measurements in Paget's disease of bone.
ανά: Walton, R, κ.ά.
Έκδοση: (1977)

Factors influencing the response to 1alpha-hydroxyvitamin D3 in patients with renal bone disease.
ανά: Kanis, J, κ.ά.
Έκδοση: (1977)

Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
ανά: Gray, R, κ.ά.
Έκδοση: (1987)

Biochemical measurements in Paget's disease of bone.
ανά: Walton, R, κ.ά.
Έκδοση: (1977)

The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
ανά: Russell, R, κ.ά.
Έκδοση: (1975)

PLASMA IMMUNOREACTIVE CALCITONIN AND BONE-DISEASE IN DIALYZED PATIENTS
ανά: Heynen, G, κ.ά.
Έκδοση: (1976)

Effects of 24,25-dihydroxy-vitamin D3 on its plasma level in man.
ανά: Kanis, J, κ.ά.
Έκδοση: (1981)

Diphosphonates in Paget's disease.
ανά: Russell, R, κ.ά.
Έκδοση: (1974)

Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responses.
ανά: Kanis, J, κ.ά.
Έκδοση: (1979)

BIOLOGICAL EFFECTS OF 1,24,25-TRIHYDROXYVITAMIN-D3 IN MAN
ανά: Cundy, T, κ.ά.
Έκδοση: (1979)

Correlation of clinical, biochemical and skeletal responses to 1alpha-hydroxyvitamin D3 in renal bone disease.
ανά: Kanis, J, κ.ά.
Έκδοση: (1977)

Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?
ανά: Kanis, J, κ.ά.
Έκδοση: (1978)

APPOSITIONAL RATES IN BONE IN PATIENTS WITH CHRONIC RENAL-DISEASE
ανά: Earnshaw, M, κ.ά.
Έκδοση: (1979)

The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
ανά: Kanis, J, κ.ά.
Έκδοση: (1977)

THERAPEUTIC ADVANTAGE OF 1-ALPHA-HYDROXYLATED COMPOUNDS OVER VITAMIN-D
ανά: Kanis, J, κ.ά.
Έκδοση: (1977)

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.
ανά: Henderson, R, κ.ά.
Έκδοση: (1974)

CALCITONIN, BONE-DISEASE, AND CHRONIC RENAL-FAILURE
ανά: Cundy, T, κ.ά.
Έκδοση: (1978)

Effective short term treatment of Paget's disease with oral etidronate.
ανά: Preston, C, κ.ά.
Έκδοση: (1986)

Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment.
ανά: Smith, R, κ.ά.
Έκδοση: (1976)

Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
ανά: Smith, R, κ.ά.
Έκδοση: (1973)

Physiological and therapeutic differences between vitamin D, its metabolites and analogues.
ανά: Kanis, J, κ.ά.
Έκδοση: (1977)

Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.
ανά: Kanis, J, κ.ά.
Έκδοση: (1977)

Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in man.
ανά: Henderson, R, κ.ά.
Έκδοση: (1974)

Physiological and therapeutic differences between vitamin D, its metabolites and analogues
ανά: Kanis, J, κ.ά.
Έκδοση: (1977)

VITAMIN-DS, MINERALS AND RENAL BONE-DISEASE
ανά: Kanis, J, κ.ά.
Έκδοση: (1979)

Everest : the man and the mountain /
ανά: Smith, J. R., author
Έκδοση: (1999)

EVIDENCE THAT ENDOGENOUS CALCITONIN PROTECTS AGAINST RENAL BONE-DISEASE
ανά: Heynen, G, κ.ά.
Έκδοση: (1976)

1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism.
ανά: Russell, R, κ.ά.
Έκδοση: (1974)

Challenges for the development of bone-forming agents in Europe
ανά: Kanis, J, κ.ά.
Έκδοση: (2014)

Challenges for the development of bone-forming agents in Europe.
ανά: Kanis, J, κ.ά.
Έκδοση: (2014)

Osteomalacia in renal disease.
ανά: Kanis, J, κ.ά.
Έκδοση: (1980)

‘Man’s inhumanity to man’ and other platitudes of avoidance and misrecognition: an analysis of visitor responses to exhibitions marking the 1807 bicentenary
ανά: Laurajane Smith
Έκδοση: (2010-11-01)

Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin.
ανά: Kanis, J, κ.ά.
Έκδοση: (1977)

The vitamin D's in chronic renal failure
ανά: Kanis, J, κ.ά.
Έκδοση: (1979)